Principia Wealth Advisory’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.55K Sell
7
-3
-30% -$654 ﹤0.01% 667
2026
Q2
$1.95K Buy
10
+4
+67% +$829 ﹤0.01% 603
2026
Q1
$1.35K Buy
6
+1
+20% +$249 ﹤0.01% 628
2025
Q4
$1.2K Sell
5
-1,333
-100% -$341K ﹤0.01% 613
2025
Q3
$366K Hold
1,338
– – 0.25% 53
2025
Q2
$345K Sell
1,338
-20
-1% -$4.77K 0.29% 40
2025
Q1
$294K Buy
1,358
+21
+2% +$4.9K 0.28% 39
2024
Q4
$306K Buy
+1,337
New +$322K 0.29% 35

Other funds holding RMD

Principia Wealth Advisory's RMD Position: Q3 2026 in Review

Principia Wealth Advisory reduced its ResMed (RMD) stake by 30% in Q3 2026, selling an estimated $654 and leaving 7 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Principia Wealth Advisory first reported a position in RMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $366K in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Principia Wealth Advisory held 7 shares of ResMed worth $1.55K as of Q3 2026.
  • Principia Wealth Advisory sold 3 ResMed shares in Q3 2026, an estimated $654.
  • ResMed made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q3 2026, its #667 holding.
  • Principia Wealth Advisory first reported a position in ResMed in Q4 2024 and has held it in 8 quarters since.
  • Principia Wealth Advisory's ResMed position peaked at $366K in Q3 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Principia Wealth Advisory's 13F filing for Q3 2026, filed 12 Nov 2026.